
Heska Corporation HSKA
Quarterly report 2023-Q1
added 05-05-2023
Heska Corporation Cash Conversion Cycle 2011-2026 | HSKA
Annual Cash Conversion Cycle Heska Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 138 | 115 | 113 | 164 | 147 | 169 | 122 | 109 | 104 | 114 | 118 | 116 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 169 | 104 | 127 |
Quarterly Cash Conversion Cycle Heska Corporation
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 165 | - | 154 | 144 | 137 | - | 118 | 102 | 110 | - | 119 | 144 | 188 | 41 | 148 | 165 | 150 | 44.1 | 148 | 148 | 140 | 39.3 | 173 | 157 | 160 | 48.1 | 118 | 133 | 125 | 24.8 | 47.9 | 57.8 | 58.8 | 0.91 | 53.5 | 52 | 55.6 | 0.81 | 65.9 | 50.9 | 59.8 | 0.77 | 65.2 | 64.9 | 70.2 | 1.02 | 72 | 77.8 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 188 | 0.77 | 93.3 |
Cash Conversion Cycle of other stocks in the Diagnostics research industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Co-Diagnostics
CODX
|
-2.46 K | $ 1.29 | -21.17 % | $ 1.72 M | ||
|
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M | ||
|
Fulgent Genetics
FLGT
|
42.4 | $ 15.7 | -3.03 % | $ 475 M | ||
|
Agilent Technologies
A
|
111 | $ 111.7 | -1.38 % | $ 34 B | ||
|
Castle Biosciences
CSTL
|
31.6 | $ 19.13 | 1.32 % | $ 555 M | ||
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
1.01 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | ||
|
Illumina
ILMN
|
142 | $ 142.54 | -0.49 % | $ 22.7 B | ||
|
Interpace Biosciences
IDXG
|
62.9 | $ 1.76 | -2.22 % | $ 7.79 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 19.97 | -2.54 % | $ 1.06 B | ||
|
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | ||
|
Lantheus Holdings
LNTH
|
97.3 | $ 93.91 | -2.86 % | $ 6.34 B | ||
|
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | ||
|
Mettler-Toledo International
MTD
|
66.4 | $ 1 031.64 | -0.99 % | $ 21.3 B | ||
|
Myriad Genetics
MYGN
|
49.3 | $ 3.58 | -1.1 % | $ 332 M | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 415.27 | -0.93 % | $ 12 B | ||
|
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M | ||
|
NeoGenomics
NEO
|
82.4 | $ 8.24 | -1.44 % | $ 1.06 B | ||
|
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | ||
|
National Research Corporation
NRC
|
29.4 | $ 18.62 | -1.64 % | $ 417 M | ||
|
Charles River Laboratories International
CRL
|
65 | $ 150.85 | -5.2 % | $ 7.48 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | ||
|
Natera
NTRA
|
81.5 | $ 186.36 | -5.36 % | $ 18.3 B | ||
|
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
42.5 | - | - | $ 19.8 B | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 25.23 | -1.06 % | $ 23.9 B | ||
|
Senseonics Holdings
SENS
|
36.1 | $ 5.77 | -0.86 % | $ 241 M | ||
|
Guardant Health
GH
|
79.6 | $ 94.92 | -3.79 % | $ 11.9 B | ||
|
Personalis
PSNL
|
-1.89 | $ 6.36 | -5.22 % | $ 568 M | ||
|
ICON Public Limited Company
ICLR
|
62 | $ 116.38 | -0.61 % | $ 9.6 B | ||
|
Soleno Therapeutics
SLNO
|
-398 | $ 53.01 | 0.04 % | $ 2.69 B | ||
|
QIAGEN N.V.
QGEN
|
122 | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
172 | $ 2.34 | -2.9 % | $ 5.38 M | ||
|
Laboratory Corporation of America Holdings
LH
|
40.3 | $ 250.4 | -1.43 % | $ 20.8 B | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 438.34 | -2.2 % | $ 165 B | ||
|
Trinity Biotech plc
TRIB
|
136 | $ 0.57 | -1.59 % | $ 205 M | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
Twist Bioscience Corporation
TWST
|
83.6 | $ 49.17 | -7.14 % | $ 2.94 B | ||
|
Waters Corporation
WAT
|
731 | $ 329.22 | -1.2 % | $ 19.6 B | ||
|
Neogen Corporation
NEOG
|
150 | $ 8.19 | -2.85 % | $ 1.78 B | ||
|
Quest Diagnostics Incorporated
DGX
|
39.5 | $ 186.61 | -0.71 % | $ 20.7 B |